Antenatal corticosteroids cut mortality for early preemies

Antenatal corticosteroids cut mortality for early preemies

(HealthDay)—For neonates born before 24 weeks of gestation, receipt of antenatal corticosteroids and active intensive treatment is associated with reduced odds of mortality to discharge, according to a review published in the April issue of Obstetrics & Gynecology.

Christina K. Park, from McMaster University in Hamilton, Canada, and colleagues conducted a systematic literature review to compare outcomes for who received or did not receive born before 24 weeks of gestation. Data were included from 17 observational studies.

The researchers found that 3,626 neonates had the primary outcome of to discharge in those receiving active intensive treatment. Mortality to discharge occurred in 58.1 percent of the intervention group versus 71.8 percent in the control group, with evidence rated as moderate quality. Compared with the control group, the antenatal corticosteroid group had reduced odds of mortality to discharge (crude adjusted odds ratio, 0.45; adjusted odds ratio, 0.48). No significant between-group differences were seen for severe morbidity.

"The available data, all observational, show reduced odds of mortality to in neonates born before 24 weeks of gestation who received antenatal corticosteroids and active intensive treatment," the authors write. "Antenatal corticosteroids should be considered for women at risk of imminent birth before 24 weeks of gestation who choose active postnatal resuscitation."


Explore further

Antenatal corticosteroid use up, even when not optimal

More information: Full Text (subscription or payment may be required)
Journal information: Obstetrics & Gynecology

Copyright © 2016 HealthDay. All rights reserved.

Citation: Antenatal corticosteroids cut mortality for early preemies (2016, March 16) retrieved 19 November 2019 from https://medicalxpress.com/news/2016-03-antenatal-corticosteroids-mortality-early-preemies.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors

User comments